[HTML][HTML] Progesterone actions and resistance in gynecological disorders

JA MacLean, K Hayashi - Cells, 2022 - mdpi.com
Estrogen and progesterone and their signaling mechanisms are tightly regulated to maintain
a normal menstrual cycle and to support a successful pregnancy. The imbalance of estrogen …

Endometrial cancer

EJ Crosbie, SJ Kitson, JN McAlpine, A Mukhopadhyay… - The Lancet, 2022 - thelancet.com
Endometrial cancer is the most common gynaecological cancer in high income countries
and its incidence is rising globally. Although an ageing population and fewer benign …

[HTML][HTML] Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma

X Yu, L Xie, J Ge, H Li, S Zhong, X Liu - Frontiers in Immunology, 2023 - frontiersin.org
Objectives The tumor microenvironment (TME) play important roles in progression of
endometrial carcinoma (EC). We aimed to assess the cell populations in TME of EC …

[HTML][HTML] Fertility-sparing strategies for early-stage endometrial cancer: stepping towards precision medicine based on the molecular fingerprint

G Gullo, G Cucinella, V Chiantera, M Dellino… - International Journal of …, 2023 - mdpi.com
Endometrial cancer represents the fifth most common cancer in women, and the most
common gynecological malignancy in developed countries [1]. Although endometrial cancer …

[HTML][HTML] Molecular basis of endometriosis and endometrial cancer: Current knowledge and future perspectives

M Terzic, G Aimagambetova, J Kunz… - International journal of …, 2021 - mdpi.com
The human endometrium is a unique tissue undergoing important changes through the
menstrual cycle. Under the exposure of different risk factors in a woman's lifetime, normal …

Endometrial carcinosarcoma

G Bogani, I Ray-Coquard, N Concin… - International Journal of …, 2023 - ijgc.bmj.com
Endometrial carcinosarcoma is a rare and aggressive high-grade endometrial carcinoma
with secondary sarcomatous trans-differentiation (conversion theory). The clinical …

p53abn endometrial cancer: understanding the most aggressive endometrial cancers in the era of molecular classification

A Jamieson, EF Thompson, J Huvila… - International Journal of …, 2021 - ijgc.bmj.com
Over the past decade, our understanding of endometrial cancer has changed dramatically
from the two-tiered clinicopathologic classification system of type I and type II endometrial …

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification

EF Thompson, J Huvila, A Jamieson, S Leung… - Modern …, 2022 - nature.com
We assessed the landscape of diagnostic pathology practice and how molecular
classification could potentially impact management of patients with endometrial cancer by …

Loss of LOXL2 promotes uterine hypertrophy and tumor progression by enhancing H3K36ac-dependent gene expression

X Lu, DE Xin, JK Du, QC Zou, Q Wu, YS Zhang… - Cancer research, 2022 - AACR
Abstract Lysyl oxidase-like 2 (LOXL2) is a member of the scavenger receptor cysteine-rich
(SRCR) repeat carrying LOX family. Although LOXL2 is suspected to be involved in histone …

[HTML][HTML] Histopathologic diagnosis of endometrial precancers: updates and future directions

H Chen, AL Strickland, DH Castrillon - Seminars in Diagnostic Pathology, 2022 - Elsevier
Early detection of endometrial cancer, especially its precancers, remains a critical and
evolving issue in patient management and the quest to decrease mortality due to …